Ilan Ganot - 31 Jan 2025 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Role
Director
Signature
/s/ David Tyronne Howton as attorney-in-fact for Ilan Ganot
Issuer symbol
SLDB
Transactions as of
31 Jan 2025
Net transactions value
$0
Form type
4
Filing time
11 Feb 2025, 16:42:16 UTC
Previous filing
29 Jan 2025
Next filing
18 Feb 2025

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLDB Restricted Stock Units Award $0 +60,000 $0.000000 60,000 31 Jan 2025 Common Stock 60,000 Wife F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock (the "RSUs").
F2 The RSUs were granted on the January 31, 2025 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.